Navigation Links
Successful Field-Trial Remediation of 1,2-DCA and VC Contaminated Groundwater in Northern Italy
Date:6/3/2009

nvironment at the site is impacted by 1,2-dichloroethane (1,2-DCA) and vinyl chloride (VC) about 300,000 and 500 ?g/L in groundwater, respectively. Knowing the general persistence of 1,2-DCA in the environment, initial laboratory tests evaluated various remedial technologies: two different chemical oxidants (ISCO) and biochemical anaerobic reduction (ISCR). Of the two oxidants tested, only the activated persulfate was effective; RegenOx showed no activity whatsoever. Although the ISCR reactions required a longer treatment time, both 1,2-DCA and VC were completely removed in less than sixty days, without the accumulation of dead-end catabolites.

The use of EHC for ISCR was subsequently chosen for field-scale test, considering its minimal geochemical impact on soil and groundwater conditions. The initial field test area was ca. 50 m2 and the total volume of saturated soil treated was ca. 700 m3. A total of 6,300 kg of EHC amendment was injected through nine injection points using direct-push technology. Groundwater monitoring from four proximal observation wells showed a widespread and sustained reduction in redox (Eh -150 mV to -450 mV) and, most significantly, within ca. 9 months the groundwater concentrations of both 1,2-DCA and VC were reduced from ca. 800,000 ?g/L to in to below the regulatory treatment standards (SSTL) of 1,500 ?g/L, with two of the monitoring wells containing < 10 ?g/L 1,2-DCA.

CONCLUSIONS

Design of full-scale site remediation using the EHC ISCR technology is being completed. Simultaneously, continued monitoring of the field site t time on-going to verify the effective reagent life and document lack of “rebound” which is typical for many other remedial technologies. Full scale implementation will employ 600 to 700 tonnes of EHC to treat an area measuring 7,000 m2 and is planned for 2009 through 2011

A complete copy of the Report is available via PDF at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related biology technology :

1. Orthocrat Announces Successful Implementation of TraumaCad at UPMC Mercy
2. Successful Phase I/II Clinical Trial Results From Cancer Patients Treated With Anti-Cancer Drug From Axelar AB
3. Symphony Medical Announces First Patient Successfully Treated With Novel Congestive Heart Failure Therapy
4. Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals
5. VeraSun Energy Selects Valero as Successful Bidder for Seven Facilities
6. Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting
7. EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology
8. Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Indevus Pharmaceuticals and Announces Subsequent Offering Period
9. DiFUSION Technologies Completes Successful Testing of Antimicrobial Spinal Implant
10. WaferGens SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program
11. GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Successful Field-Trial Remediation of 1,2-DCA and VC Contaminated Groundwater in Northern Italy
(Date:7/30/2015)... ... July 30, 2015 , ... ... Vieillard as Sales & Marketing Director. , With more than 25 years ... responsible for reinforcing Tronics’ business development activities worldwide. He brings to the company ...
(Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative veterinary medicine ... its canine osteoarthritis stem cell product, currently under development for FDA approval. The ... be marketed in the US by Aratana. This product, termed AT-016, is an ...
(Date:7/30/2015)... customers across the globe, ISN improves the efficiency and effectiveness of contractor management systems. ... and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In More Than 80 Countries ... Headquartered in Dallas, TX , ISN has additional offices in ...
(Date:7/30/2015)...  Discovery Laboratories, Inc. (Nasdaq: DSCO ) ... $1.0M tranche under a previously awarded Phase II ... up to $3.0 million to support continued development ... potential medical countermeasure to mitigate acute and chronic/late-phase ... initial $1.0 million under this grant in October ...
Breaking Biology Technology:Tronics appoints Francois Vieillard as Sales and Marketing Director 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... ("Angiotech") (NASDAQ: ANPI , TSX: ANP), a ... the commencement,of a cash tender offer of the ... that will result in an aggregate purchase price ... Premiums" listed in the,table below) of $165 million ...
... Limited (LSE:SHP, NASDAQ: SHPGY), the global specialty,biopharmaceutical company, will ... Results press release will be issued at: ... Investor meeting and conference call time: 14:30 BST ... conference call:, Angus Russell, Chief Executive Officer, Graham ...
... BIOCITECH, France, July 3 Cellectis SA today,announced ... over the use of Cellectis, patents covering certain ... human therapies, including,the development of fully human monoclonal ... an upfront of 12,450,000$ from Regeneron.,In addition, Regeneron ...
Cached Biology Technology:Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 2Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 3Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 4Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 5Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 6Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 7Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 8Shire Ltd - Second Quarter 2008 Results Date Notification - 31 July 2008 2Cellectis and Regeneron Sign an Agreement Over the use of Homologous Recombination Technology 2
(Date:7/2/2015)... GOTHENBURG, Sweden , July 2, 2015 ... fingerprint sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor ... is one of FPC,s distributors in Asia ... Q4 2015. The sensors will be used by smartphone manufacturers ... 268 MSEK is included in the communicated revenue guidance of ...
(Date:6/25/2015)... -- According to a new market ... Technology, Material (Optical Prism, Piezoelectric, Capacitive & Adhesives), ... & Geography - Global Forecast to 2014 - ... expected to reach $14,500.07 Million by 2020, at ... 76 market Tables and 109 Figures spread through ...
(Date:6/24/2015)... June 24, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that Sharp has selected its ... authentication for its latest flagship smartphone device, the ... 200 million shipments of its fingerprint ID sensor ... strength, scalability and leadership in the biometrics market ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... deformity that cases a depression in the chest wall inhibits ... of 327 patients published in the Journal of Pediatrics ... anecdotally, that children with more severe pectus excavatum report more ... exercise intolerance," said one of the study,s lead authors, Dr. ...
... are common during the year following a traumatic brain injury ... tend to occur more often among females and those with ... Journal of Neurotrauma , a peer-reviewed journal published by ... at www.liebertpub.com/neu More than 70% of patients ...
... have been working for years to nail down the ... hormones, called brassinosteroids, send from a protein on the ... New research from Carnegie scientists Tae-Wuk Kim and Zhiyong ... Francisco, isolated another link in this chain. Fully understanding ...
Cached Biology News:New component of a plant steroid-activated pathway discovered 2
Homo sapiens jumping translocation breakpoint...
One-step, microplate or cuvet, colorimetric 530nm, detection limit 0.16mg/dL in serum or plasma. Procedure: 10 min....
MOUSE ANTI HUMAN NPM...
Edited by D. Rickwood, T.C. Ford and J.T. Steensgaard (1994) Compiles core data required by researchers carrying out any centrifugal separation, whether working with cells, organelles or macromolec...
Biology Products: